Skip to content

New boosted PIs should be used with T-20 for maximum impact, say new US guidelines

Discordant CD4 increase of 25 cells/mm3 confers clinical benefit despite advanced disease

Detectable viral loads in patients on antiretroviral therapy causes slow development of resistance

IAS: New NRTI D-d4FC active in treatment-experienced patients

IAS: Tipranavir combined with T-20 achieves good virologic results in the highly treatment experienced

Proof-of-concept study shows benefits of Kaletra / efavirenz combination

Viral load ‘blips’ on NNRTIs linked to low-level viral replication but not treatment failure

XIV International HIV Drug Resistance Workshop: Clinical response

Lipid-lowering drugs better at lowering blood fats caused by protease inhibitors than switching to NNRTI